drugset / Trial / NCT02097043

Phase I Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of DA-7218 in Healthy Male Volunteers

NCT02097043 ↗

Phase 1 Completed 31 enrolled Dong-A ST Co., Ltd.
RandomizedParallel-groupQuadruple-blindBasic science

Summary

This study is a phase I clinical trial for evaluating the pharmacokinetics and safety/tolerability of DA-7218 in healthy male volunteers.

Timeline

Start
2014-05
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject DA-7218 Unknown 200 mg Oral
Subject DA-7218 Unknown 400 mg Oral
Subject DA-7218 Unknown 600 mg Oral

Indications

No indication recorded.